Efficacy and Safety of Ivacaftor in Patients Aged 6 to 11 Years with Cystic Fibrosis with a G551D Mutation

Davies, Jane C., Wainwright, Claire E., Canny, Gerard J., Chilvers, Mark A., Howenstine, Michelle S., Munck, Anne, Mainz, Jochen G., Rodriguez, Sally, Li, Haihong, Yen, Karl, Ordonez, Claudia L. and Ahrens, Richard (2013) Efficacy and Safety of Ivacaftor in Patients Aged 6 to 11 Years with Cystic Fibrosis with a G551D Mutation. American Journal of Respiratory and Critical Care Medicine, 187 11: 1219-1225. doi:10.1164/rccm.201301-0153OC


Author Davies, Jane C.
Wainwright, Claire E.
Canny, Gerard J.
Chilvers, Mark A.
Howenstine, Michelle S.
Munck, Anne
Mainz, Jochen G.
Rodriguez, Sally
Li, Haihong
Yen, Karl
Ordonez, Claudia L.
Ahrens, Richard
Title Efficacy and Safety of Ivacaftor in Patients Aged 6 to 11 Years with Cystic Fibrosis with a G551D Mutation
Journal name American Journal of Respiratory and Critical Care Medicine   Check publisher's open access policy
ISSN 1073-449X
1535-4970
Publication date 2013-06
Sub-type Article (original research)
DOI 10.1164/rccm.201301-0153OC
Volume 187
Issue 11
Start page 1219
End page 1225
Total pages 7
Place of publication New York, NY, U.S.A.
Publisher American Thoracic Society
Collection year 2014
Language eng
Keyword cystic fibrosis
cystic fibrosis transmembrane conductance regulator protein
cystic fibrosis
pulmonary
G551D-CFTR mutation
sweat test
Pulmonary-Function
Cftr Potentiator
Growth
Children
Disease
Identification
Pathogenesis
Vx-770
Gene
Q-Index Code C1
Q-Index Status Confirmed Code
Institutional Status UQ

 
Versions
Version Filter Type
Citation counts: TR Web of Science Citation Count  Cited 112 times in Thomson Reuters Web of Science Article | Citations
Scopus Citation Count Cited 133 times in Scopus Article | Citations
Google Scholar Search Google Scholar
Created: Sun, 14 Jul 2013, 00:11:22 EST by System User on behalf of School of Medicine